Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Accumulated Expenses (2010 - 2026)

Updated

Biogen (BIIB) posted Accumulated Expenses of $23 million for Q4 2011, down 73.9% from $88 million a year earlier.

Analysis

Biogen (BIIB) Accumulated Expenses (2010 - 2026) Analysis & Trends

  • In prior years, Biogen's Accumulated Expenses was $88 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.01 Bn
Jun 30, 2026 2.63 Bn
Mar 31, 2026 2.55 Bn
Dec 31, 2025 2.80 Bn
Sep 30, 2025 2.77 Bn
Jun 30, 2025 2.66 Bn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 2.81 Bn
Sep 30, 2024 2.76 Bn
Jun 30, 2024 2.47 Bn
Mar 31, 2024 2.35 Bn
Dec 31, 2023 2.62 Bn
Sep 30, 2023 3.84 Bn
Jun 30, 2023 2.48 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.52 Bn
Sep 30, 2022 3.31 Bn
Jun 30, 2022 3.30 Bn
Mar 31, 2022 2.23 Bn
Dec 31, 2021 2.54 Bn
API Access

Biogen Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BIIB&period=max&api_key=YOUR_API_KEY